<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02116699</url>
  </required_header>
  <id_info>
    <org_study_id>NS-72393-360</org_study_id>
    <nct_id>NCT02116699</nct_id>
  </id_info>
  <brief_title>Oropharyngeal Administration of Mother's Colostrum for Premature Infants</brief_title>
  <official_title>Oropharyngeal Administration of Mother's Colostrum: Health Outcomes of Premature Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Gerber Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundacion Para La Investigacion Hospital La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NorthShore University HealthSystem</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extremely premature (BW&lt;1250g) infants are at high risk for morbidity and mortality. Own
      mother's colostrum (OMC) and milk (OMM) protect against neonatal morbidity and are rich in
      immune factors which may provide immunostimulatory effects when administered oropharyngeally
      to extremely premature infants during the first weeks of life. The investigators hypothesize
      that infants who receive oropharyngeal mother's colostrum and milk will have significantly
      lower rates of infection and improved health outcomes, compared to infants who receive a
      placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extremely premature (BW&lt;1250g) infants are at high risk for morbidity and mortality. Own
      mother's colostrum (OMC) and milk (OMM) protect against neonatal morbidity and are rich in
      immune factors which may provide immunostimulatory effects when administered oropharyngeally
      to extremely premature infants during the first weeks of life. This 5-year
      placebo-controlled, double-blind randomized controlled trial will evaluate the safety,
      efficacy and health outcomes of oropharyngeal administration of OMC/OMM in a sample of 622
      (total patients enrolled) extremely premature infants with the following aims: Aim 1. To
      determine if oropharyngeal administration of OMC/OMM to extremely premature infants will
      reduce the risk of late-onset sepsis or death as the primary outcome, and necrotizing
      enterocolitis and ventilator-associated pneumonia as pre-planned secondary outcomes. Aim 2:
      To determine if extremely premature infants who receive OMC/OMM via the oropharyngeal route
      have a shorter time to reach full enteral feeds and a shorter length of hospital stay. Aim 3:
      To determine if oropharyngeal administration of OMC/OMM will have immunostimulatory effects
      for extremely premature infants, as measured by (A) enhancement of gastrointestinal (fecal)
      microbiota, (B) improvement in antioxidant defense maturation or reduction of pro-oxidant
      status, and (C) maturation of immunostimulatory effects as measured by changes in urinary
      lactoferrin. Results will confirm whether extremely premature infants demonstrate a
      host-immune response to this intervention and whether there is a beneficial effect on common
      morbidities in these high risk patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of of late-onset sepsis</measure>
    <time_frame>at 40 wks CGA</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of necrotizing enterocolitis</measure>
    <time_frame>at 40 weeks CGA</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of ventilator-associated pneumonia</measure>
    <time_frame>at 40 weeks CGA</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to reach full enteral feeds</measure>
    <time_frame>at 40 wks CGA</time_frame>
    <description>defined as 150 mL/kg/day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>at 40 wks CGA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentrations of lactoferrin in urine</measure>
    <time_frame>1 day, 3 days, 32 weeks CGA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in stool microbiome</measure>
    <time_frame>3 days, 2 weeks, 32 weeks CGA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in urinary biomarkers of oxidative stress</measure>
    <time_frame>3 days,</time_frame>
    <description>1 day, 3 days, 1 week, 32 weeks CGA</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">622</enrollment>
  <condition>Infection</condition>
  <condition>Enterocolitis, Necrotizing</condition>
  <condition>Ventilator-associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>oropharyngeal mother's milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.2 mL every 2 hours for 48 hours beginning within 96 hours post-birth, followed by 0.2 mL every 3 hours until 32 weeks post conceptional age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oropharyngeal sterile water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.2 mL every 2 hours for 48 hours beginning within 96 hours post-birth, followed by 0.2 mL every 3 hours until 32 weeks post conceptional age</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oropharyngeal mother's milk</intervention_name>
    <description>Application of 0.2 mL of own mother's milk onto the infant's oral mucosa, followed by brief swabbing, for an initial treatment period of every 2 hours for 48 hours, followed by an extended treatment period of every 3 hours until 32 weeks corrected gestational age</description>
    <arm_group_label>oropharyngeal mother's milk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oropharyngeal sterile water</intervention_name>
    <description>Application of 0.2 mL of sterile water onto the infant's oral mucosa, followed by brief swabbing, for an initial treatment period of every 2 hours for 48 hours, followed by an extended treatment period of every 3 hours until 32 weeks corrected gestational age</description>
    <arm_group_label>oropharyngeal sterile water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Birthweight &lt;1250g Mother plans to pump and provide breastmilk for at least 2 months
        Absence of congenital anomalies Admission to the neonatal intensive care unit within 24
        hours after birth Ability to begin protocol within 96 hours of life

        Exclusion Criteria:

        Gastrointestinal anomaly Birth asphyxia (pH&lt;7.0) Maternal +HIV status Maternal drug or
        substance use that precludes infant from receiving mother's milk Tracheoesophageal fistula
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy A Rodriguez, PhD APN NNP</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nancy A Rodriguez, PhD APN NNP</last_name>
    <phone>847-733-5202</phone>
    <email>nrodriguez@northshore.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Caplan, MD</last_name>
    <phone>847-570-2530</phone>
    <email>mcaplan@northshore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NorthShore University health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Rodriguez, PhD APN NNP</last_name>
      <phone>847-733-5202</phone>
      <email>nrodriguez@northshore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advocate Children's Hospital-Park Ridge</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Preetha Prazad, MD</last_name>
      <phone>847-723-5313</phone>
      <email>preetha.prazad@advocatehealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Ladino, MD</last_name>
      <phone>973-971-5488</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Childrens Hospital</name>
      <address>
        <city>Paterson</city>
        <state>New Jersey</state>
        <zip>07503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adel Zauk, MD</last_name>
      <phone>973-754-2500</phone>
      <email>zauka@sjhmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Betty Cameron Women &amp; Children's Hospital</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28403-6024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Moya, MD</last_name>
      <phone>910-667-2724</phone>
      <email>fernando.moya@ccneo.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>April 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2014</study_first_posted>
  <last_update_submitted>September 23, 2016</last_update_submitted>
  <last_update_submitted_qc>September 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem</investigator_affiliation>
    <investigator_full_name>Nancy Rodriguez</investigator_full_name>
    <investigator_title>Neonatal Nurse Practitioner</investigator_title>
  </responsible_party>
  <keyword>oropharyngeal</keyword>
  <keyword>colostrum</keyword>
  <keyword>mother's milk</keyword>
  <keyword>premature</keyword>
  <keyword>neonate</keyword>
  <keyword>infection</keyword>
  <keyword>necrotizing enterocolitis</keyword>
  <keyword>ventilator-associated pneumonia</keyword>
  <keyword>breastmilk</keyword>
  <keyword>human milk</keyword>
  <keyword>late-onset sepsis</keyword>
  <keyword>microbiome</keyword>
  <keyword>antioxidant</keyword>
  <keyword>enteral feeds</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

